Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linyi Youkang Biotechnology Co., Ltd. is a leading high-tech enterprise based in China that specializes in the research, production, and distribution of high-value nutritional lipids, specifically DHA (Docosahexaenoic acid) and ARA (Arachidonic acid). Established in 2001, the company leverages a comprehensive bioengineering platform encompassing fermentation, physical extraction, and microencapsulation to provide high-purity oils and powders. Its products are widely utilized as essential ingredients in infant formula, dietary supplements, and pharmaceutical applications globally. Linyi Youkang maintains rigorous quality standards, holding certifications such as US FDA GRAS and EU Novel Food status, which facilitate its role as a key supplier in international markets. The company also operates a dedicated functional lipid research center and collaborates with several academic institutions to drive technological innovation in nutritional science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linyi Youkang Biotechnology.